Kepler Capital Markets Upgrades Danone (OTCMKTS:DANOY) to Strong-Buy

Danone (OTCMKTS:DANOY) was upgraded by Kepler Capital Markets to a “strong-buy” rating in a research report issued on Wednesday,Zacks.com reports.

Several other equities analysts have also commented on the company. Deutsche Bank Aktiengesellschaft lowered Danone from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Morgan Stanley reissued an “overweight” rating on shares of Danone in a research report on Thursday, January 29th. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Danone in a research report on Wednesday, October 29th. Finally, Citigroup restated a “neutral” rating on shares of Danone in a research note on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Danone Stock Up 4.1%

Danone stock opened at $17.06 on Wednesday. Danone has a 1-year low of $13.81 and a 1-year high of $18.63. The company has a current ratio of 0.95, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average of $17.30 and a 200-day moving average of $17.39.

About Danone

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.